BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

510 related articles for article (PubMed ID: 28511884)

  • 1. The Impact of Quality Variations on Patients Undergoing Surgery for Renal Cell Carcinoma: A National Cancer Database Study.
    Lawson KA; Saarela O; Abouassaly R; Kim SP; Breau RH; Finelli A
    Eur Urol; 2017 Sep; 72(3):379-386. PubMed ID: 28511884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Features associated with recurrence beyond 5 years after nephrectomy and nephron-sparing surgery for renal cell carcinoma: development and internal validation of a risk model (PRELANE score) to predict late recurrence based on a large multicenter database (CORONA/SATURN Project).
    Brookman-May S; May M; Shariat SF; Xylinas E; Stief C; Zigeuner R; Chromecki T; Burger M; Wieland WF; Cindolo L; Schips L; De Cobelli O; Rocco B; De Nunzio C; Feciche B; Truss M; Gilfrich C; Pahernik S; Hohenfellner M; Zastrow S; Wirth MP; Novara G; Carini M; Minervini A; Simeone C; Antonelli A; Mirone V; Longo N; Simonato A; Carmignani G; Ficarra V;
    Eur Urol; 2013 Sep; 64(3):472-7. PubMed ID: 22748912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hospital Quality Metrics for Radical Cystectomy: Disease Specific and Correlated to Mortality Outcomes.
    Khanna A; Saarela O; Lawson K; Finelli A; Haber GP; Lee B; Abouassaly R
    J Urol; 2019 Sep; 202(3):490-497. PubMed ID: 31009290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hospital-level Effects Contribute to Variations in Prostate Cancer Quality of Care.
    Lawson KA; Daignault K; Abouassaly R; Khanna A; Martin L; Goldenberg M; Hamilton RJ; Loblaw A; Warde P; Saarela O; Finelli A
    Eur Urol Oncol; 2021 Jun; 4(3):494-497. PubMed ID: 32938571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for acute kidney injury after radical nephrectomy and inferior vena cava thrombectomy for renal cell carcinoma.
    Shin S; Han Y; Park H; Chung YS; Ahn H; Kim CS; Cho YP; Kwon TW
    J Vasc Surg; 2013 Oct; 58(4):1021-7. PubMed ID: 23591189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship of postoperative complications with in-hospital outcomes and costs after renal surgery for kidney cancer.
    Kim SP; Leibovich BC; Shah ND; Weight CJ; Borah BJ; Han LC; Boorjian SA; Thompson RH
    BJU Int; 2013 Apr; 111(4):580-8. PubMed ID: 22564425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Multigene Signature Based on Cell Cycle Proliferation Improves Prediction of Mortality Within 5 Yr of Radical Nephrectomy for Renal Cell Carcinoma.
    Morgan TM; Mehra R; Tiemeny P; Wolf JS; Wu S; Sangale Z; Brawer M; Stone S; Wu CL; Feldman AS
    Eur Urol; 2018 May; 73(5):763-769. PubMed ID: 29249291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal Cell Carcinoma with Isolated Lymph Node Involvement: Long-term Natural History and Predictors of Oncologic Outcomes Following Surgical Resection.
    Gershman B; Moreira DM; Thompson RH; Boorjian SA; Lohse CM; Costello BA; Cheville JC; Leibovich BC
    Eur Urol; 2017 Aug; 72(2):300-306. PubMed ID: 28094055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Three-dimensional tumour volume and cancer-specific survival for patients undergoing nephrectomy to treat pT1 clear-cell renal cell carcinoma.
    Jorns J; Thiel DD; Lohse CM; Williams A; Arnold ML; Cheville JC; Leibovich BC; Parker AS
    BJU Int; 2012 Oct; 110(7):956-60. PubMed ID: 22300498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A non-cancer-related survival benefit is associated with partial nephrectomy.
    Sun M; Trinh QD; Bianchi M; Hansen J; Hanna N; Abdollah F; Shariat SF; Briganti A; Montorsi F; Perrotte P; Karakiewicz PI
    Eur Urol; 2012 Apr; 61(4):725-31. PubMed ID: 22172373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overall survival and development of stage IV chronic kidney disease in patients undergoing partial and radical nephrectomy for benign renal tumors.
    Kaushik D; Kim SP; Childs MA; Lohse CM; Costello BA; Cheville JC; Boorjian SA; Leibovich BC; Thompson RH
    Eur Urol; 2013 Oct; 64(4):600-6. PubMed ID: 23280319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting Oncologic Outcomes in Renal Cell Carcinoma After Surgery.
    Leibovich BC; Lohse CM; Cheville JC; Zaid HB; Boorjian SA; Frank I; Thompson RH; Parker WP
    Eur Urol; 2018 May; 73(5):772-780. PubMed ID: 29398265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytoreductive nephrectomy in patients with synchronous metastases from renal cell carcinoma: results from the International Metastatic Renal Cell Carcinoma Database Consortium.
    Heng DY; Wells JC; Rini BI; Beuselinck B; Lee JL; Knox JJ; Bjarnason GA; Pal SK; Kollmannsberger CK; Yuasa T; Srinivas S; Donskov F; Bamias A; Wood LA; Ernst DS; Agarwal N; Vaishampayan UN; Rha SY; Kim JJ; Choueiri TK
    Eur Urol; 2014 Oct; 66(4):704-10. PubMed ID: 24931622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hospital volume and outcomes of robot-assisted partial nephrectomy.
    Xia L; Pulido JE; Chelluri RR; Strother MC; Taylor BL; Raman JD; Guzzo TJ
    BJU Int; 2018 Jun; 121(6):900-907. PubMed ID: 29232025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hospital-Level Factors Associated with Anesthesia-Related Adverse Events in Cesarean Deliveries, New York State, 2009-2011.
    Guglielminotti J; Deneux-Tharaux C; Wong CA; Li G
    Anesth Analg; 2016 Jun; 122(6):1947-56. PubMed ID: 27195637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variability in Partial Nephrectomy Outcomes: Does Your Surgeon Matter?
    Dagenais J; Bertolo R; Garisto J; Maurice MJ; Mouracade P; Kara O; Chavali J; Li J; Nelson R; Fergany A; Abouassaly R; Kaouk JH
    Eur Urol; 2019 Apr; 75(4):628-634. PubMed ID: 30396636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Routine adrenalectomy in patients with locally advanced renal cell cancer does not offer oncologic benefit and places a significant portion of patients at risk for an asynchronous metastasis in a solitary adrenal gland.
    Weight CJ; Kim SP; Lohse CM; Cheville JC; Thompson RH; Boorjian SA; Leibovich BC
    Eur Urol; 2011 Sep; 60(3):458-64. PubMed ID: 21514718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicted versus observed 30-day perioperative outcomes using the ACS NSQIP surgical risk calculator in patients undergoing partial nephrectomy for renal cell carcinoma.
    Blair BM; Lehman EB; Jafri SM; Kaag MG; Raman JD
    Int Urol Nephrol; 2018 Jul; 50(7):1249-1256. PubMed ID: 29868938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regional Variation in 30-Day Ischemic Stroke Outcomes for Medicare Beneficiaries Treated in Get With The Guidelines-Stroke Hospitals.
    Thompson MP; Zhao X; Bekelis K; Gottlieb DJ; Fonarow GC; Schulte PJ; Xian Y; Lytle BL; Schwamm LH; Smith EE; Reeves MJ
    Circ Cardiovasc Qual Outcomes; 2017 Aug; 10(8):. PubMed ID: 28798017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preoperative nutritional status is an important predictor of survival in patients undergoing surgery for renal cell carcinoma.
    Morgan TM; Tang D; Stratton KL; Barocas DA; Anderson CB; Gregg JR; Chang SS; Cookson MS; Herrell SD; Smith JA; Clark PE
    Eur Urol; 2011 Jun; 59(6):923-8. PubMed ID: 21295907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.